AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV on September 1, 2021. For the year ending December 31, 2020, Bio-Connect BV reported turnover of approximately €14 million. The transaction is expected to have only a marginal positive effect on AddLife’s earnings per share in the 2021 financial year. AddLife AB (publ) (OM:ALIF B) completed the acquisition of Bio-Connect BV on September 1, 2021.